(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
'Zootopia 2' movie reviews: A heartwarming, hysterical and earnest 'ode to community' - 2Delta flight bound for Atlanta makes emergency landing after engine issue
- 3The Craft of Do-It-Yourself Home Stylistic layout: Change Your Space
- 4The Most Important Crossroads in Olympic History
- 5Artemis 2 moon rocket gets 'America 250' paint job | Space photo of the day for Dec. 23, 2025
- These HGTV stars made a pledge to keep their kids off smartphones. Here's how it's going.
- Astounding Treehouses All over the Planet
- 2026 will be the year NASA astronauts fly around the moon again — if all goes to plan
- Eating ultra-processed foods could raise precancerous polyp risk for women under 50, according to research
- Atorvastatin recall may affect hundreds of thousands of patients – and reflects FDA’s troubles inspecting medicines manufactured overseas
- Novo Nordisk cuts Wegovy price in South Africa for a second time
- Decrease in Home Buy Credits and Home loan Renegotiating Rates: An Outline of Latest things
- California officials warn against foraging wild mushrooms after deadly poisoning outbreak
- Supercharge Your Remote Work Arrangement with These Game-Changing Instruments
